Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-center, Open-label, Pilot Study to Investigate the Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients.

NCT01469884 is registered in ClinicalTrials.gov with Irmandade Santa Casa de Misericórdia de Porto Alegre as lead sponsor.

NCT NCT01469884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01469884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-center, Open-label, Pilot Study to Investigate the Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients.
Lead sponsor
Irmandade Santa Casa de Misericórdia de Porto Alegre
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2011
Completion date
April 30, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, renal allograft